Roth JA - Search Results

1

Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.

Pataer A, Raso MG, Correa AM, Behrens C, Tsuta K, Solis L, Fang B, Roth JA, Wistuba II, Swisher SG. Pataer A, et al. Among authors: roth ja. Clin Cancer Res. 2010 Nov 15;16(22):5522-8. doi: 10.1158/1078-0432.CCR-10-0753. Epub 2010 Oct 7. Clin Cancer Res. 2010. PMID: 20930042 Free PMC article.

2

Prognostic significance of computed tomography in resected N2 lung cancer.

Cybulsky IJ, Lanza LA, Ryan MB, Putnam JB Jr, McMurtrey MM, Roth JA. Cybulsky IJ, et al. Among authors: roth ja. Ann Thorac Surg. 1992 Sep;54(3):533-7. doi: 10.1016/0003-4975(92)90449-e. Ann Thorac Surg. 1992. PMID: 1324657

3

Combination immunotherapy for advanced lung cancer.

Yang SC, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. J Natl Cancer Inst Monogr. 1992;(13):197-201. J Natl Cancer Inst Monogr. 1992. PMID: 1327033 Clinical Trial.

4

Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.

Putnam EA, Yen N, Gallick GE, Steck PA, Fang K, Akpakip B, Gazdar AF, Roth JA. Putnam EA, et al. Among authors: roth ja. Surg Oncol. 1992 Feb;1(1):49-60. doi: 10.1016/0960-7404(92)90056-q. Surg Oncol. 1992. PMID: 1341235

5

New approaches to treating early lung cancer.

Roth JA. Roth JA. Cancer Res. 1992 May 1;52(9 Suppl):2652s-2657s. Cancer Res. 1992. PMID: 1562995 Review.

6

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Res. 1991 Jul 15;51(14):3669-76. Cancer Res. 1991. PMID: 1648441 Clinical Trial.

7

Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).

Zatopek NK, Holoye PY, Ellerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang AC, Glisson BS. Zatopek NK, et al. Among authors: roth ja. Am J Clin Oncol. 1991 Oct;14(5):427-32. doi: 10.1097/00000421-199110000-00013. Am J Clin Oncol. 1991. PMID: 1659177

8

Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma.

Casson AG, Putnam JB, Natarajan G, Johnston DA, Mountain C, McMurtrey M, Roth JA. Casson AG, et al. Among authors: roth ja. Cancer. 1992 Feb 1;69(3):662-8. doi: 10.1002/1097-0142(19920201)69:3<662::aid-cncr2820690311>3.0.co;2-i. Cancer. 1992. PMID: 1730117

9

Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.

Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Mukhopadhyay T, et al. Among authors: roth ja. Cancer Res. 1991 Mar 15;51(6):1744-8. Cancer Res. 1991. PMID: 1998965

10

Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha.

Yang SC, Owen-Schaub L, Mendiguren-Rodriguez A, Grimm EA, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. J Thorac Cardiovasc Surg. 1990 Jan;99(1):8-12; discussion 12-3. J Thorac Cardiovasc Surg. 1990. PMID: 2152954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,251 results

Search Page

Filters